Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Piotr Boguradzki"'
Autor:
Joanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Magdalena Topczewska, Martyna Maciejewska, Magdalena Dutka, Jan Maciej Zaucha, Anna Szmigielska-Kapłon, Mateusz Nowicki, Magdalena Olszewska-Szopa, Agnieszka Szeremet, Anna Czyż, Magdalena Kozioł, Marek Hus, Joanna Mańko, Iwona Hus, Joanna Romejko-Jarosińska, Anna Kopińska, Grzegorz Helbig, Krzysztof Mądry, Piotr Boguradzki, Małgorzata Król, Emilian Snarski, Patrick J. Hayden, Krzysztof Jamroziak, Jadwiga Dwilewicz-Trojaczek, Grzegorz Władysław Basak
Publikováno v:
Cancers, Vol 16, Iss 14, p 2588 (2024)
Salvage autologous hematopoietic cell transplantation (auto-HCT) may be used to treat relapse of plasma cell myeloma occurring after previous auto-HCT. When an insufficient number of hematopoietic stem cells have been stored from the initial harvest,
Externí odkaz:
https://doaj.org/article/1b79081e07b640719c206003b8ac4802
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
COVID-19 has become the biggest public health problem and one of the most important causes of death in many countries in the world. SARS-CoV-2 infection is most likely to be fatal in elderly patients with concomitant diseases. In this article we pres
Externí odkaz:
https://doaj.org/article/ca7e955e58674b46b904c4fec9251da9
Autor:
Piotr Boguradzki
Publikováno v:
Szpiczak plazmocytowy. Diagnozowanie i leczenie. WGLS Hematologia ISBN: 9788301229887
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a29cebfd10ca0658b911cdb355c52f97
https://doi.org/10.53271/wglshem2023.1.002
https://doi.org/10.53271/wglshem2023.1.002
Autor:
Iwona Hus, Bogusław Machaliński, Mariola Sedzimirska, Jan Maciej Zaucha, Krzysztof Czyżewski, Grzegorz Helbig, Katarzyna Drabko, Adam Fronczak, Olga Zając-Spychała, Ewa Lech-Marańda, Agnieszka Wierzbowska, Krzysztof Kałwak, Agnieszka Druzd-Sitek, Bartłomiej Baumert, Malgorzata Sobczyk-Kruszelnicka, Ewa Lutwin, Dorota Hawrylecka, Katarzyna Smalisz, Tomasz Wróbel, Beata Piątkowska-Jakubas, Kazimierz Hałaburda, Piotr Rzepecki, Marek Hus, Sebastian Giebel, Agnieszka Sobkowiak-Sobierajska, Grzegorz W. Basak, Edyta Cichocka, Aleksandra Krasowska-Kwiecień, Jacek Wachowiak, Anna Czyż, Jan Styczyński, Adam Walter-Croneck, Piotr Boguradzki, Jarosław Dybko, Anna Łojko, Marek Ussowicz, Lidia Gil, Maria Bieniaszewska, Tomasz Szczepański, Jolanta Goździk, Agnieszka Piekarska, Agnieszka Zaucha-Prażmo
Publikováno v:
Acta Haematologica Polonica. 52:528-542
Infections are still a major reason of morbidity and one of the most common causes of death after hematopoietic cell transplantation (HCT). Antimicrobial prophylaxis plays a crucial role in decreasing non-relapse mortality after HCT. The objective of
Autor:
Piotr Boguradzki, Grzegorz W. Basak, Ewelina Kmin, Jarosław Biliński, Ewa Karakulska-Prystupiuk, Wiesław Wiktor Jędrzejczak, Karolina Szczypińska, Joanna Drozd-Sokołowska, Marcin Chlebus, Agnieszka Tomaszewska, Krzysztof Mądry, Jadwiga Dwilewicz-Trojaczek
Publikováno v:
Annals of Hematology
Secondary immunodeficiencies are frequently observed after allo-HSCT. The efficacy of subcutaneous IgG preparations in this population is unknown. A retrospective single-institution study involved 126 adult patients transplanted in 2012–2019 for he
Autor:
Piotr Boguradzki, Kamila Skwierawska, Piotr Kacprzyk, Anna Waszczuk-Gajda, Joanna Drozd-Sokołowska, Marita Rachid Chehab, Wiesław Wiktor Jędrzejczak, Grzegorz W. Basak, Krzysztof Woźniak
Publikováno v:
OncoReview. 10:134-138
Cancer-related microangiopathic hemolytic anemia is rarely recognized as a paraneoplastic syndrome with a very poor prognosis in cancer patients. The treatment and prognosis are significantly different from that in other thrombotic microangiopathies,
Autor:
Katarzyna Kobylinska, Pyush Vyas, Emilian Snarski, Anna Rodziewicz-Lurzynska, Anna Waszczuk-Gajda, Beata Blajer, Agnieszka Stefaniak, Jarosław Biliński, Artur Jurczyszyn, Hanna Zborowska, Magdalena Feliksbrot-Bratosiewicz, David H. Vesole, Małgorzata Król, Grzegorz W. Basak, Katarzyna Krzanowska, J. Drozd-Sokolowska, Mateusz Ziarkiewicz, Wiesław Wiktor Jędrzejczak, Paweł Kozłowski, Kamila Skwierawska, Jolanta Malyszko, Maria Król, Przemyslaw Biecek, Elżbieta Urbanowska, Jadwiga Dwilewicz-Trojaczek, Agnieszka Tomaszewska, Krzysztof Mądry, Piotr Boguradzki, Martyna Maciejewska
Publikováno v:
Transplantation Proceedings. 52:2186-2192
Renal impairment (RI) is one of the multiple myeloma (MM)-defining events for initiating therapy. After induction therapy, high-dose chemotherapy followed by autologous peripheral blood stem cell transplant (ASCT) remains the standard of care for tra
Autor:
Waldemar Sawicki, Artur Jurczyszyn, Kazimierz Hałaburda, Krzysztof Jamroziak, Grzegorz Helbig, Piotr Boguradzki, Malgorzata Sobczyk-Kruszelnicka, Sonia Dębek, Jarosław Dybko, Lidia Gil, Aleksandra Gołos, Bartosz Pula, Krzysztof Warzocha
Publikováno v:
Advances in Medical Sciences. 65:429-436
Purpose In this multicenter retrospective analysis of the Polish Myeloma Group we assessed the real-life application of allogeneic transplantations (alloHCT) in multiple myeloma (MM) outside clinical trials in Poland. Methods Anonymized clinical data
Autor:
Grzegorz W. Basak, Joanna Romejko-Jarosinska, Magdalena Kozioł, Wojciech Sachs, Jadwiga Dwilewicz-Trojaczek, Mateusz Nowicki, Joanna Mańko, Krzysztof Mądry, Anna Szmigielska-Kapłon, Katarzyna Kobylińska, Marek Hus, Anna Waszczuk-Gajda, Przemyslaw Biecek, Iwona Hus, Mariola Sedzimirska, Małgorzata Król, Joanna Drozd-Sokołowska, Piotr Boguradzki
Publikováno v:
Leukemialymphoma. 62(13)
Salvage autologous hematopoietic stem cell transplantation (auto-HSCT) constitutes a therapeutic option for a group of well-selected patients with relapsed multiple myeloma (MM). However, if an insufficient number of stem cells were harvested and sto
Autor:
Wojciech Jurczak, Monika Joks, Piotr Boguradzki, Agnieszka Giza, Grzegorz Mazur, Katarzyna Krawczyk, Dagmara Zimowska-Curylo, Bogdan Ochrem, Monika Długosz-Danecka, Michal Szymczyk
Publikováno v:
Postępy Higieny i Medycyny Doświadczalnej, Vol 73, Pp 303-309 (2019)
Aim: Mantle cell lymphoma (MCL) patients have poor prognosis, due to development of chemoresistance in relapsing patients. Therefore, despite the features of indolent lymphoma at presentation, consolidation and/or maintenance strategies to achieve mi